HPV in skin transformation into cancer

  • Research type

    Research Study

  • Full title

    Role of human papillomavirus in skin transformation into skin cancer stem cells

  • IRAS ID

    259447

  • Contact name

    Girish K Patel

  • Contact email

    patelgk@cardiff.ac.uk

  • Sponsor organisation

    Cardiff University

  • Duration of Study in the UK

    5 years, 0 months, 0 days

  • Research summary

    Patients who receive an organ transplant often require lifelong immunosuppression to prevent organ rejection. This group of patients have a higher incidence rate of cancer compared to the general population, attributable to reactivation of latent viral infections such as Epstein Barr virus-associated Hodgkin’s (B-cell) lymphomas. In particular cutaneous squamous cell carcinoma (SCC) is the most common malignancy in organ transplant recipients (OTR), with an approximately 250-fold increased incidence over background risk. \n\nSkin cancers affect more than half of organ transplant recipients and are a major cause of morbidity and mortality. Beta-human papillomaviruses (βHPVs) are a group of DNA viruses, which have the ability to establish persistent infections in skin. In the healthy individual the immune system suppress viral replication and/or expansion of infected cells. However in immunosuppressed individuals, such as organ transplant recipients, reactivation of latent βHPVs is responsible for field cancerization: large areas of actinic keratosis, Bowenoid keratosis and Bowens disease. The phenomenon of field cancerisation predisposes to SCC and provides strong evidence to support the role of these viruses in skin cancer development in immunosuppressed individuals.\n\nWe hypothesise that there may be an indirect link between HPV and SCC formation, which involves field cancerization. It has been shown that βHPV transgenic mice develop skin keratoses within which SCC develop spontaneously. Since we have also shown that SCC growth is dependent upon skin cancer stem cells defined by the expression of the cell surface protein CD133, we propose to determine whether field cancerization represents an early expansion of cancer stem cells or precursors keratinocyte stem cells.\n\nThis is a retrospective study involving laboratory-based research on 300 participant samples from those with a previous histological diagnosis of actinic or Bowenoid keratoses will be used to demonstrate βHPV viral proteins in healthy and OTR patients.\n

  • REC name

    North of Scotland Research Ethics Committee 2

  • REC reference

    19/NS/0012

  • Date of REC Opinion

    6 Feb 2019

  • REC opinion

    Further Information Favourable Opinion